University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Microbiology Department Faculty Publication
Series

Microbiology

2021

Evidence for the Role of CYP51A and Xenobiotic Detoxification in
Differential Sensitivity to Azole Fungicides in Boxwood Blight
Pathogens
Stefanos Stravoravdis
Robert E. Marra
Nicholas R. LeBlanc
JoAnne Crouch
Jonathan P. Hulvey

Follow this and additional works at: https://scholarworks.umass.edu/micro_faculty_pubs
Part of the Biochemistry Commons, Chemistry Commons, and the Molecular Biology Commons

International Journal of

Molecular Sciences
Article

Evidence for the Role of CYP51A and Xenobiotic Detoxification
in Differential Sensitivity to Azole Fungicides in Boxwood
Blight Pathogens
Stefanos Stravoravdis 1,2 , Robert E. Marra 3 , Nicholas R. LeBlanc 4,5 , Jo Anne Crouch 4 and Jonathan P. Hulvey 2, *
1

2
3

4

5

*



Citation: Stravoravdis, S.; Marra,
R.E.; LeBlanc, N.R.; Crouch, J.A.;
Hulvey, J.P. Evidence for the Role of
CYP51A and Xenobiotic
Detoxification in Differential
Sensitivity to Azole Fungicides in
Boxwood Blight Pathogens. Int. J.
Mol. Sci. 2021, 22, 9255. https://
doi.org/10.3390/ijms22179255
Academic Editor: Raffaella

Department of Microbiology, University of Massachusetts Amherst, Amherst, MA 01003, USA;
sstravoravdi@umass.edu
Biology Department, Eastern Connecticut State University, Willimantic, CT 06226, USA
Department of Plant Pathology and Ecology, The Connecticut Agricultural Experiment Station, New Haven,
CT 06504, USA; Robert.Marra@ct.gov
Mycology and Nematology Genetic Diversity and Biology Laboratory, United States Department of
Agriculture, Agricultural Research Service, Beltsville, MD 20705, USA; nicholas.leblanc@usda.gov (N.R.L.);
joanne.crouch@usda.gov (J.A.C.)
ARS Research Participation Program, Oak Ridge Institute for Science and Education, Oak Ridge,
TN 37831-0117, USA
Correspondence: hulveyj@easternct.edu

Abstract: Boxwood blight, a fungal disease of ornamental plants (Buxus spp.), is caused by two
sister species, Calonectria pseudonaviculata (Cps) and C. henricotiae (Che). Compared to Cps, Che is
documented to display reduced sensitivity to fungicides, including the azole class of antifungals,
which block synthesis of a key fungal membrane component, ergosterol. A previous study reported
an ergosterol biosynthesis gene in Cps, CYP51A, to be a pseudogene, and RNA-Seq data confirm that a
functional CYP51A is expressed only in Che. The lack of additional ergosterol biosynthesis genes showing significant differential expression suggests that the functional CYP51A in Che could contribute to
reduced azole sensitivity when compared to Cps. RNA-Seq and bioinformatic analyses found that
following azole treatment, 55 genes in Cps, belonging to diverse pathways, displayed a significant decrease in expression. Putative xenobiotic detoxification genes overexpressed in tetraconazole-treated
Che encoded predicted monooxygenase and oxidoreductase enzymes. In summary, expression of
a functional CYP51A gene and overexpression of predicted xenobiotic detoxification genes appear
likely to contribute to differential fungicide sensitivity in these two sister taxa.

Maria Balestrini

Keywords: Calonectria; ergosterol; demethylation inhibitors; azole; xenome; pseudogene
Received: 24 June 2021
Accepted: 24 August 2021
Published: 26 August 2021

1. Introduction
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affiliations.

Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).

Boxwood blight is a disease of native and commercially grown boxwood (Buxus spp.)
caused by two emerging fungal plant pathogens: Calonectria pseudonaviculata (Cps) and
C. henricotiae (Che) [1,2]. During infection, plants undergo stem and foliar lesioning, rapid
defoliation, and die back, and preventative fungicides are required for disease management.
Cps infects Buxus plants globally, while Che is restricted to Europe [1–4]. Both species were
previously classified as distinct genotypes of Cps, but multi-locus phylogenetic analysis,
comparative genomics, and phenotypic differences supported their placement into separate
sister species, with the erection of Che [3,5].
Various classes of fungicides and antifungal drugs are used to control plant and
animal diseases caused by fungal pathogens, including boxwood blight [6–8]. One group
of antifungals, the azole class (or demethylation inhibitors/DMIs), impede production
of ergosterol, a vital component of fungal cell membranes [9,10]. This class of antifungal
chemicals has broad application in both agriculture and medicine and is used to treat
and prevent a broad range of plant and animal diseases. Azoles inhibit fungal growth by
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affecting membrane integrity and are targeted to the active site of sterol 14α-demethylase,
a cytochrome P450 protein encoded by the CYP51 gene, which catalyzes demethylation of
lanosterol in the ergosterol biosynthesis pathway. Differential sensitivity towards select
azoles, such as the triazoles tetraconazole and propiconazole, has been demonstrated by
in vitro comparisons between Cps and Che, where the latter species tolerated significantly
higher exposure to the chemicals in a poison plate assay [3].
As with known antimicrobial compounds, repeated exposure to azoles places selective
pressure on fungi, by which the CYP51 target-site may gain resistance-conferring mutations
that inhibit azole binding [11–13]. In addition to mutations in the active site, overexpression
of the CYP51 gene is also known to confer varying levels of resistance to azoles in diverse
fungi [13,14]. Select lineages, including Cps and Che, are reported to possess three CYP51
paralogs, denoted as CYP51A, CYP51B, and CYP51C [9,13,15,16]. From a comparative
analysis of a worldwide collection of Cps and Che genomes, a CYP51A pseudogene was
found in all examined Cps isolates from populations spanning four continents, but not
in Che [16]. A premature stop codon occurring upstream of the translated active site,
presumably disabling CYP51A function, was hypothesized to play a role in differential
azole sensitivity seen in Cps relative to Che [16]. However, ergosterol biosynthesis is a multistaged process involving over 20 genes, overexpression of which may serve as putative
determinants of decreased azole sensitivity [17,18].
Transcriptomics studies have reported that when exposed to antifungals, fungi with
reduced azole sensitivity display increased expression of genes from the xenome, a threephase detoxification pathway found in fungi and other eukaryote lineages [19–22]. During
the first phase, proteins oxidize harmful substances entering the cell [20]. In this context,
cytochrome P450 monooxygenase enzymes aid metabolism of xenobiotics, such as antifungal drugs and plant secondary metabolites [20,21]. Although specific enzymes in this
family can contribute to routine cellular activities/functions, such as lipid processing and
synthesis of secondary metabolites, their role to aiding xenobiotic detoxification can be
vital to non-target site mechanisms of tolerance to antifungals [21,22].
The second phase of detoxification involves deployment of proteins that perform
chemical conjugation (modification) of xenobiotic substances [20]. Through conjugation
the oxidized drug/toxin can be rendered more soluble, facilitating removal from the cell.
Alternatively, the compound could be primed for breakdown or compartmentalized within
the fungal cell. Among the proteins involved in this stage of detoxification are transferases,
largely glutathione transferases [20,23,24]. The latter behaves by conjugating glutathione
onto toxin molecules, facilitating efflux and thus reducing toxicity [23,24].
The final phase, known as efflux, is the removal of toxins, minimizing the opportunity
for toxins to bind and inhibit cellular functions [13,20]. The ATP-binding cassette (ABC)
transporters, ATP-dependent pumps that transport substances across membranes, are
known to export toxins, including azoles, from the cell, and are often overexpressed in
azole-resistant fungi [22,25,26]. Additionally, members of the major facilitator superfamily
(MFS) of active transport proteins efflux azoles in parallel with ion movement along an
electrochemical gradient [27,28]. Evidence in Alternaria has demonstrated that the loss
of functional MFS transporters was linked with increased sensitivity towards fungicides,
demonstrating the importance of efflux transporters in antifungal tolerance [28].
In light of previous findings on differential fungicide sensitivity in these two closely
related sister species causing boxwood blight disease, we set out in the present study to
examine gene expression patterns that may underpin their differential azole fungicide sensitivity [3,16]. We analyzed RNA-Seq expression data of control and tetraconazole-treated Cps
and Che to examine CYP51 paralog expression patterns, and to identify differentially overand underexpressed genes in Cps and Che likely associated with xenobiotic detoxification
or ergosterol biosynthesis [12,20,21]. Such genetic determinants could serve as potential
targets for future functional studies and aid in teasing apart mechanisms of antifungal
resistance to inform development and screening of novel antifungal compounds.
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2. Results
2.1. Sensitivity of Cps and Che to Select Azole Fungicides
Che isolate CB45 had insignificantly higher EC50 and EC85 values when treated with
either myclobutanil or tebuconazole (Table 1). Cps CT1 had an insignificantly higher EC50
value and an insignificantly lower EC85 value following treatment with triadimefon when
compared to Che CB45 (0.86 times larger and ~1.41 times lower, respectively). However,
Che isolate CB45 demonstrated substantially larger EC50 values when treated with tetraconazole (five times higher) or propiconazole (three times higher) compared with Cps
CT1. CB45 also had a significantly larger EC85 value following tetraconazole treatment
(over 16 times larger).
Table 1. Effective concentrations of fungicides restrict Cps and Che growth.
Fungicide
Myclobutanil
Tetraconazole *
Tebuconazole
Triadimefon
Propiconazole

EC50 , ppm

EC85 , ppm

Cps

Che

Cps

Che

0.43
0.20
0.10
5.00
0.05

0.57
1.00
0.13
4.30
0.15

3.10
0.60
0.56
26.20
0.56

4.60
9.70
0.86
37.00
0.84

* Values in bolded text show significant difference in EC50 and EC85 values.

2.2. Quality Assessment of RNA-Seq Alignments
The number of CT1 control reads mapping to the CT1 genome ranged from 3,601,223
(~90.03%) to 3,773,581 (~94.34%), while the number of tetraconazole-treated reads mapping
to the CT1 genome ranged from 3,589,726 (~89.74%) to 3,663,272 (~91.58%). For Che,
the number of CB45 control reads mapping to the CB45 genome ranged from 3,747,123
(~93.68%) to 3,759,744 (~93.99%), while the number of tetraconazole-treated reads mapping
to the CB45 genome ranged from 3,663,325 (~91.58%) to 3,767,407 (~94.19%).
2.3. Predicted Detoxification Genes in CT1 and CB45
CT1 and CB45 had 504 and 544 genes, respectively, possessing at least one of the
four InterPro IDs associated with phases one and three of fungal xenobiotic detoxification
(Tables S2 and S3) [20]. Using the broad GO name search, we identified 831 and 940 genes
from CT1 and CB45, respectively, predicted to encode proteins with transferase activity
(acetyl-CoA, glutathione, acetyl, etc.) (Tables S4 and S5).
2.4. Differentially Expressed Genes in Tetraconazole-Treated Cps
For all expression analyses, log2 FC (fold change) values greater than 1.5 were considered overexpressed, as previously specified by [21], while log2 FC values below −1.5 were
considered underexpressed. Sixteen genes were statistically, significantly overexpressed
in tetraconazole-treated CT1 compared to untreated CT1 (Table 2), and 55 genes whose
expression significantly declined in CT1 following exposure to tetraconazole. Using our
multi-blast analyses, we saw that 64 of these 71 total genes in Cps CT1 had a corresponding
hit in Che CB45. None of the genes significantly overexpressed in CT1 were substantially
underexpressed in CB45 (Table 2; Figure 1A). Rather, seven genes underexpressed in
CT1 matched with overexpressed genes in CB45, though only one of which (a predicted
2,4-dienoyl-CoA reductase precursor, g12476) mapped to an overexpressed CB45 gene
(log2 FC > 1.5). Though generally not reaching our minimum threshold for a meaningful
change in gene expression, genes in Cps CT1 following tetraconazole treatment were more
likely to decline in expression.

Int. J. Mol. Sci. 2021, 22, 9255

4 of 20

Table 2. Significantly, differentially overexpressed genes in tetraconazole-treated Cps CT1 when compared to untreated CT1.
Name

Description (Blastp Result)

e-Value

Mean
Similarity (%)

Fold
Change

log2 FC *

p-Value

g3755
g4897
g7954
g4550
g12983
g2466
g9321
g3936
g11975
g8
g8362
g6303
g4296
g10806
g5767
12006
g11629
g6683
g1573
g8085
g6821
g2224
g10919
g4950
g7786

Amine oxidase
NmrA family transcriptional regulator
Cytochrome P450 monooxygenase
Hypothetical protein AK830_g2355
Non-ribosomal peptide synthetase
Polyamine transporter 4
Putative uncharacterized oxidoreductase
Beta-glucosidase B
Hypothetical protein CEP53_001993
Cellobiose dehydrogenase
Membrane protein
Predicted protein
Short chain dehydrogenase
Cytochrome P450 monooxygenase
Benzodiazapine receptor
Phytoene dehydrogenase
Unnamed protein product
AhpC/TSA family protein
Endochitinase 1 precursor
Related to ankyrin 3
Hypothetical protein AK830_g533
Copper resistance-associated P-type ATPase
Hypothetical protein FOYG_12748
Uncharacterized protein FVRRES_10874
Hypothetical protein PEX2_036530
Related to TAP42, component of the Tor
signaling pathway
Hypothetical protein AK830_g6151
Hypothetical protein
Cytochrome P450 monooxygenase FUM15
NAD(P)-binding domain protein
Related to ARCA protein
Hypothetical protein AK830_g11121
Hypothetical protein FCULG_00008984
Tannase and feruloyl esterase
Hypothetical protein S40288_06769
CVNH domain-containing protein
Beta-glucosidase 1
Related to signal peptide protein
Predicted protein
Related to quinate transport protein
Related to RNQ1-prion, epigenetic modifier of
protein function
Succinate-semialdehyde dehydrogenase
Hypothetical protein CSUB01_04341
Hypothetical protein CEP52_010997
30 kDa heat shock protein
Hypothetical protein BFJ68_g11167
No successful annotation
ph protein
Hypothetical protein
Heat shock protein 30
Hypothetical protein CDD83_2148
Hypothetical protein
Related to Zn-dependent oxidoreductases
Predicted protein
Lipase 2
Aurofusarin/rubrofusarin efflux pump AFLT
Related to isoamyl alcohol oxidase
Hypothetical protein DV735_g44, partial
Hypothetical protein CEP53_004141
Transmembrane protein
Hypothetical protein AK830_g8487
Putative transporter
Hypothetical protein CNYM01_02327

0
2.86E-171
3.94E-173
9.20E-115
0
0
1.53E-124
0
2.59E-98
1.32E-167
9.24E-60
1.37E-21
4.53E-142
0
7.02E-110
0
3.81E-83
3.46E-121
0
1.03E-144
0
1.42E-93
6.12E-44
1.61E-115
7.21E-71

82.66
70.67
87.1
74.11
64.5
82.16
71.69
80.2
82.1
70.38
72.66
71.72
86.45
93.45
88.73
76.86
51.01
88.47
82.40
52.21
82.08
64.75
46.12
55.96
67.85

7.44
4.56
3.95
3.17
3.15
3.01
2.78
2.51
2.50
2.43
2.33
2.31
2.21
2.15
2.13
2.13
−2.00
−2.01
−2.01
−2.04
−2.04
−2.05
−2.06
−2.06
−2.07

2.90
2.19
1.98
1.66
1.66
1.59
1.48
1.33
1.32
1.28
1.22
1.21
1.14
1.10
1.09
1.09
−1.00
−1.01
−1.01
−1.03
−1.03
−1.04
−1.04
−1.04
−1.05

0.0020
0.0021
0.0043
5.63 × 10−8
0.0044
1.97 × 10−13
0.0041
2.68 × 10−4
1.47 × 10−11
0.0061
3.54 × 10−5
3.81 × 10−4
4.66 × 10−17
1.00 × 10−9
7.92 × 10−8
4.90 × 10−4
0.0015
0.0033
6.65 × 10−73
2.05 × 10−6
1.01 × 10−22
0.0011
0.0089
4.86 × 10−9
3.91 × 10−11

0

87.44

−2.10

−1.07

1.38 × 10−4

2.77E-115
0
0
2.54E-118
0
0
0
0
3.29E-96
1.00E-76
0
4.11E-90
3.17E-42
0

52.64
71.60
93.17
76.44
69.08
79.89
72.15
74.16
62.25
64.11
76.92
60.69
54.15
91.93

−2.12
−2.13
−2.14
−2.18
−2.20
−2.21
−2.21
−2.22
−2.23
−2.24
−2.26
−2.26
−2.26
−2.29

−1.09
−1.09
−1.10
−1.13
−1.14
−1.14
−1.14
−1.15
−1.16
−1.16
−1.17
−1.18
−1.18
−1.19

9.04 × 10−11
2.27 × 10−4
0.0173
4.35 × 10−5
2.12 × 10−6
4.70 × 10−40
0.0149
0.0463
3.62 × 10−4
1.13 × 10−47
0.0027
0.0202
8.24 × 10−12
0.0283

1.29E-129

67.60

−2.30

−1.20

3.31 × 10−52

0
9.35E-59
6.25E-114
1.64E-100
0
–
4.28E-156
9.53E-118
1.21E-107
1.87E-71
152E-57
0
0
0
0
0
3.18E-51
5.28E-65
2.43E-107
1.99E-82
0
1.69E-176

91.28
57.37
63.88
80.62
54.02
–
82.60
67.61
79.46
62.41
65.38
85.94
83.81
63.85
91.34
77.69
46.99
53.38
79.26
60.83
86.43
55.57

−2.36
−2.40
−2.40
−2.47
−2.47
−2.49
−2.56
−2.58
−2.73
−2.74
−2.77
−2.78
−2.86
−3.02
−3.04
−3.15
−3.25
−3.26
−3.29
−3.36
−3.41
−3.46

−1.24
−1.26
−1.27
−1.30
−1.30
−1.32
−1.36
−1.37
−1.45
−1.45
−1.47
−1.47
−1.52
−1.59
−1.61
−1.65
−1.70
−1.71
−1.72
−1.75
−1.77
−1.79

4.45 × 10−45
0.0077
0.012
3.92 × 10−7
8.85 × 10−10
0.0227
2.05 × 10−61
1.07 × 10−5
1.24 × 10−6
0.0087
1.58 × 10−35
0.0122
7.78 × 10−28
4.58 × 10−6
0.0015
0.0243
0.0289
6.35 × 10−8
1.13 × 10−4
2.49 × 10−25
0.0468
7.71 × 10−13

g9725
g2437
g9807
g11724
g10528
g168
g6699
g4515
g7647
g2422
g10964
g10999
g6402
g176
g3909
g4209
g8262
g6192
g7723
g6378
g8973
g6167
g6992
g12366
g5885
g8937
g11752
g5903
g6754
g8520
g12477
g9066
g174
g4674
g6874
g8665
g11475
g6191
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Table 2. Cont.
Name

Description (Blastp Result)

e-Value

Mean
Similarity (%)

Fold
Change

log2 FC *

p-Value

g12476
g11916
g11954
g5478
g10880
g5555
g11706
g8925

2,4-dienoyl-CoA reductase precursor
Hypothetical protein CSHISOI_01161
Hypothetical protein AK830_g7182
Protein alcS
Putative dienelactone hydrolase protein
Hypothetical protein AK830_g4498
MFS general substrate transporter
No successful annotation

8.00E-175
2.78E-33
6.58E-111
6.31E-101
1.73E-150
8.40E-104
4.10E-128
–

76.95
44.31
71.82
77.15
80.87
80.07
70.32
–

−4.14
−4.16
−5.51
−5.81
−6.49
−6.72
−6.80
−11.32

−2.05
−2.06
−2.46
−2.54
−2.70
−2.75
−2.77
−3.50

0.0038
0.0282
0.0097
0.0060
0.0025
5.88 × 10−19
0.0183
0.0074

* The table is arranged from most to least differentially overexpressed gene (highest fold change and log2 FC to least).

Figure 1. Heatmaps of significantly, differentially overexpressed and underexpressed genes in Cps and Che following
tetraconazole treatment according to log2 FC values. (A) Every gene significantly overexpressed or underexpressed in
Cps is displayed along with the best corresponding multi-blast gene hit in Che. (B) All significantly expressed genes in
Che are shown with their corresponding blastp hit in the Cps genome. In (A,B), we excluded genes from Cps or Che that
did not possess any blastp hits within the other species’ genome. The genes are arranged according to increasing p-value
(starting with the underexpressed genes). The name hypothetical protein was abbreviated to Hyp. protein. Heatmaps were
generated from log2 FC values using GraphPad Prism version 9.1.2 for Windows (GraphPad Software; San Diego, CA, USA,
www.graphpad.com).
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We observed that only six of the genes had log2 FC values greater than 1.5 (Table 2;
Figure 2A). An amine oxidase gene was the most overexpressed among treated isolates
(log2 FC ≈ 2.90), though two of the genes were identified as encoding cytochrome P450
monooxygenases (one of which with a log2 FC > 1.50), which can be putatively linked to
chemical detoxification [20,21]. At least three genes were predicted to produce dehydrogenases (none with log2 FC > 1.50), and one of the genes was predicted to yield a polyamine
transporter protein (log2 FC ≈ 1.59), which may furthermore be associated with detoxification [20]. There were 18 significantly underexpressed genes in CT1 whose log2 FC values
fell below -1.5 (Table 2; Figure 2B). Various proteins predicted to possess diverse functions
declined in expression following azole treatment, such as a prion associated with epigenetic
activity (g4209). However, three protein transporters exhibited large reductions in gene
expression: a predicted efflux pump (g12477; log2 FC ≈ −1.61), a putative transporter
(g11475, log2 FC ≈ −1.77), and a potential MFS transporter (g11706; log2 FC ≈ −2.77).

Figure 2. Cont.
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Figure 2. Bar charts of log2 FC values of all differentially overexpressed and underexpressed genes in Che and Cps following
tetraconazole treatment. Differentially expressed genes in Cps are displayed in (A,B), while differentially expressed genes in
Che are shown in (C,D). Hypothetical protein was abbreviated to Hyp. protein for simplicity. Note that the Cps isolates had
over double the number of differentially underexpressed genes than overexpressed genes, some of which were associated
with efflux and detoxification activity. The genes are arranged according to increasing p-value. The data was plotted using
GraphPad Prism version 9.1.2 for Windows (GraphPad Software; San Diego, CA, USA, www.graphpad.com).

The overexpressed genes in tetraconazole-treated Cps CT1 possessed a variety of different GO terms, though only the GO annotations associated with the membrane/integral component of the membrane appeared relatively common (occurring in eight of the 16 genes)
(Figure 3A). Tetraconazole treatment appears to impact a large array of proteins in Cps
CT1, such as proteins putatively associated with the nucleus (GO label occurring in five of
55 genes) or carrying out metal/zinc binding (occurring three and five times, respectively)
and redox reactions (seen six times among 55 genes) (Figure 3B). Similar to the overexpressed genes, tetraconazole appears to significantly impact genes annotated to synthesize
membrane proteins (observed in 19 of the 55 underexpressed genes).
2.5. Differentially Expressed Genes in Tetraconazole-Treated Che
Seventeen genes were statistically, differentially overexpressed in tetraconazole-treated
CB45 compared to untreated CB45 (Table 3), and another 17 genes were significantly, differentially underexpressed in the tetraconazole-treated Che CB45. We observed that 22 of these
34 differentially over- and underexpressed genes successfully matched to a gene in Cps CT1
in our multi-blast analysis (Figure 1B). No gene underexpressed in tetraconazole-treated
CB45 matched to a strongly overexpressed gene (log2 FC > 1.5) in tetraconazole-treated
CT1 (Figure 1B); however, seven of the overexpressed genes in Che did match Cps genes
whose expressions were underexpressed (log2 FC < −1.5) or unaffected (log2 FC ≈ 0) following azole treatment (Figure 1B). In only one of these matches, the Che gene, the putative
FAD-dependent oxidoreductase (g8987), had a log2 FC exceeding 1.5, demonstrating that expression of this gene was particularly impacted by tetraconazole treatment in Che compared
to the closest matching gene in Cps.
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Figure 3. Cont.
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Figure 3. Bar charts displaying the total count for each GO annotation associated with significantly, differentially overexpressed and underexpressed genes in tetraconazole-treated Cps and Che. In (A,B), the counts are respectively shown for
overexpressed and underexpressed genes in tetraconazole-treated Cps, while (C,D) show GO annotation counts for the
overexpressed and underexpressed genes in Che. Note that F: refers to GO annotations describing Molecular Functions. A
Biological Process is denoted by P:, and Cellular Components are denoted by C:. The data were plotted using GraphPad Prism
version 9.1.2 for Windows (GraphPad Software; San Diego, CA, USA, www.graphpad.com).
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Table 3. Significantly, differentially overexpressed genes in tetraconazole-treated Che CB45 when compared to untreated CB45.
Name

Description (Blastp Result)

e-Value

Mean
Similarity (%)

Fold
Change

log2 FC *

p-Value

g9154
g8011
g5429
g8424
g5428
g1551
g8987
g8537
g1569
g5809
g2437
g937
g5236
g6263
g3800
g3704
g9615
g7108
g2227
g1520
g11957
g1807

Hypothetical protein CEP51_000673
Polyamine transporter 4
Cytochrome P450 monooxygenase
Uracil permease
Cytochrome-b5 reductase
Flavonol synthase
Putative fad -dependent oxidoreductase protein
Benzoate 4-monooxygenase
Quinone oxidoreductase
Aldehyde dehydrogenase
Related to choline dehydrogenase
Hypothetical protein
Gluconate 5-dehydrogenase
Hypothetical protein CEP53_001993
Hypothetical protein NECHADRAFT_97613
Uncharacterized protein FFFS_03043
Hypothetical protein CEP53_001289
Indoleamine 2,3-dioxygenase
Hypothetical protein AK830_g4468
Hypothetical protein AK830_g4498
Hypothetical protein M419DRAFT_5450
Predicted protein
Short chain dehydrogenase/reductase family
protein
Hypothetical protein AK830_g1682
Related to aspartyl proteinase SAP3 precursor
No successful annotation
Hypothetical protein AK830_g9553
Hypothetical protein FOTG_02367
Related to inhibitor of calcineurin
Aminotriazole resistance protein
Subtilisin-like proteinase Mp1
Hypothetical protein DL763_001348
Hypothetical protein NECHADRAFT_67887
Hypothetical protein

2.20E-132
0
0
0
0
0
0
0
0
0
0
0
0
2.24E-100
3.70E-162
0
3.14E-132
0
1.43E-24
6.07E-105
3.76E-89
2.77E-42

76.62
81.96
93.05
75.19
84.22
89.89
82.94
89.37
78.15
80.98
85.31
79.28
95.34
82.91
76.9
64.92
79.07
84.17
58.42
80.02
52.21
65.74

5.29
3.91
3.85
3.48
3.48
3.23
2.99
2.97
2.73
2.68
2.56
2.56
2.39
2.32
2.20
2.20
2.06
−2.00
−2.00
−2.01
−2.03
−2.07

2.40
1.97
1.94
1.80
1.80
1.69
1.58
1.57
1.45
1.42
1.36
1.36
1.26
1.22
1.14
1.13
1.04
−1.00
−1.00
−1.01
−1.02
−1.05

0.0025
2.31 × 10−25
5.11 × 10−34
0.0023
3.68 × 10−39
0.0013
0.0018
0.0015
0.0034
2.43 × 10−4
6.02 × 10−4
0.0038
0.0027
4.46 × 10−11
2.14 × 10−9
1.43 × 10−16
8.46 × 10−4
2.72 × 10−7
1.21 × 10−4
1.24 × 10−18
2.57 × 10−44
1.34 × 10−30

1.21E-113

70.07

−2.07

−1.05

0.0016

1.79E-33
0
–
2.46E-77
0
2.41E-114
0
1.38E-164
1.90E-49
1.14E-67
0

54.49
71.46
–
57.73
53.82
86.65
60.56
69.22
60.11
73.96
58.51

−2.09
−2.11
−2.14
−2.23
−2.27
−2.28
−2.64
−2.96
−6.03
−7.42
−7.89

−1.06
−1.07
−1.10
−1.16
−1.19
−1.19
−1.40
−1.57
−2.59
−2.89
−2.98

6.10 × 10−9
2.77 × 10−22
1.80 × 10−6
9.33 × 10−7
4.28 × 10−18
2.30 × 10−85
7.04 × 10−24
2.13 × 10−4
0.0046
6.48 × 10−4
3.57 × 10−4

g6618
g10262
g2895
g3319
g10017
g10337
g5103
g13846
g10436
g5443
g6520
g7560

* The table is arranged from most to least differentially overexpressed gene (highest fold change and log2 FC to least).

Eight of the overexpressed CB45 genes had log2 FC > 1.50. The most overexpressed
gene with a predicted function encoded a polyamine transporter 4 protein (log2 FC ≈ 1.97),
followed by a cytochrome P450 monooxygenase (log2 FC ≈ 1.94) and a cytochrome-b5
reductase (log2 FC ≈ 1.80) (Table 3; Figure 2C). Several of these genes were thus annotated
to have functions generally associated with xenobiotic detoxification activity [20]. Among
the underexpressed genes in Che, four had log2 FC values below −1.5, and only two
(a predicted tyrosinase, g7560, according to our conserved domain search and a proteinase)
had predicted function (Table 3; Figure 2D). Though possessing a log2 FC value of roughly
−1.4 and failing to reach our thresholds, there was a gene predicted to be associated with
aminotriazole resistance that was underexpressed in Che.
When focusing on the GO annotations for these differentially over- and underexpressed genes, we noted that overexpressed genes in tetraconazole-treated CB45 tended to
be associated with oxidoreductase activity (GO label occurred seven times among 17 genes)
and redox processes (occurred in 10 of the 17 genes) (Figure 3C). A relatively high prevalence of overexpressed genes also tended to be linked to the cell membrane (occurred in five
of 17 genes). For the underexpressed genes, the only GO names that prevalently re-occurred
were those associated with the membrane or the integral component of the membrane
(both being observed in seven of the 17 genes). Hence, tetraconazole exposure appeared to
largely reduce expression of select genes associated with the cellular membrane.
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2.6. CYP51A and CYP51B Expression Levels
In Cps isolate CT1, reads were mapped to the CYP51A pseudogene (g5325), though
expression was low and statistically insignificant between the control and tetraconazoletreated cultures (CPM < 2; p-value > 0.05). The CYP51B gene (g5734) was considered
significantly overexpressed in the treated culture based on p-value (<0.05), but the log2 FC
value failed to reach our threshold of 1.5 (~0.61).
Both the CYP51A (g2358) and CYP51B (g9283) genes were significantly overexpressed
in the tetraconazole-treated, versus the untreated, Che CB45 culture (CYP51A: p-value ≈ 0.03;
CYP51B: p-value << 0.05). However, in both instances, the log2 FC values were less than 1.5
(CYP51A: ~0.63; CYP51B: ~0.46). The above data indicates that the expression patterns of
the CYP51 paralogs in Cps and Che were largely unaffected by tetraconazole treatment.
2.7. Prediction of Ergosterol Biosynthesis Genes
There were nine genes in CB45 predicted to play a role in ergosterol biosynthesis using
our GO name search (Table 4). Two pairs of these genes were annotated to fulfill the same
function (cytochrome P450 61; NADPH-cytochrome P450 reductase) and matched to the
same genes in Cps according to our multi-blast analyses (g3336 and g9924, respectively).
One of these genes, the predicted cytochrome P450 61 g133, had 100% identity to Che g1530
and Cps g3336 but was halted by a putative premature stop codon, upstream of predicted
protein domains in the amino acid sequence of g1530. Although reads mapped to this
gene, it is possible that Che g133 encodes a pseudogene unable to contribute to ergosterol
biosynthesis, which may be complemented by g1530 in Che. Using data from [17] and
NCBI blastp searches against Fusarium species, we identified an additional 17 predicted
ergosterol biosynthesis genes in CB45 (Table 5). Notably, only one gene in the sensitive
species, Cps g12006 (Table 4), showed significant overexpression in tetraconazole-treated
CT1 (Table 1; Figure 1A, Figure 2A). No predicted ergosterol biosynthesis gene in CB45
show significant differences in gene expression.
Table 4. Putative ergosterol biosynthesis genes in Che and Cps identified using a GO term search.
Name

Description (Blastp Result)

GO Name-P:ergosterol biosynthesis process
g6498
NADH-cytochrome b5 reductase 2
g133 *
cytochrome P450 61
g7816
e3 ubiquitin-protein ligase hula
g13550
putative squalene synthase
g1530
cytochrome P450 61
g12864
NADPH-cytochrome P450 reductase
g9740
phytoene dehydrogenase
g5865
probable sterol C-24 reductase (ERG4)
g3859
NADPH-cytochrome P450 reductase

Min e-Value

Cps % Identity

Cps Genes

0
1.1E-166
0
0
0
0
0
0
0

100
100
99.92
99.86
99.69
99.50
99.08
99.02
75.25

g4129
g3336
g5528
g3858
g3336
g9924
g12006
g5534
g9924

* This gene contained no predicted protein domains but shares 100% similarity with Che g1530 and Cps g3336, aligning only to the first
108 amino acids of both genes.
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Table 5. Putative ergosterol biosynthesis genes in Che and Cps identified by Fusarium blastp.
Name

Description (Blastp Result)

g10523

Acetyl-CoA acetyltransferase (ERG10)
3-hydroxy-3-methylglutaryl-coenzyme
A reductase (HMGCR)
mevalonate kinase (ERG12)
predicted protein (ERG8)
isopentenyl-diphosphate
Delta-isomerase (IDI)
Farnesyl pyrophosphate synthase (FPS)
Farnesyl pyrophosphate synthase (FPS)
squalene synthase (ERG9)
squalene monooxygenase (ERG1)
geranylgeranyl pyrophosphate
synthase (GPS)
lanosterol synthase (ERG7)
delta(14)-sterol reductase (ERG3 or
ERG24)
methylsterol monooxygenase (ERG25)
3-keto-steroid reductase (ERG27)
predicted protein (ERG28)
C-8 sterol isomerase (ERG2)
cytochrome P450 61 (ERG5)

* g9796
g9170
g13304
g11758
g6524
g2103
g13550
g13589
g13485
g13972
* g8604
g7626
g2642
g13957
g12891
g12992

Fusarium GenBank
Accession
TVY72719.1
CAA63970.1,
sp|P0CT44.1|
TVY77487.1
TVY72023.1

Cps Genome Multi-Blast
Min e-Value
Cps % Identity
Cps Genes
0

99.92

g3826

0

99.72

g7570

0
0

99.67
99.92

g10401
g9882

EWY96464.1

0

99.87

g9857

sp|S0E627.1|
sp|Q92235.1|
EWY95524.1
TVY72423.1

0
0
0
0

99.29
99.81
99.86
99.87

g9279
g10129
g3858
g9959

sp|Q92236.1|

0

99.59

g2678

TVY78064.1
ABB48844.1,
TVY78591.1
TVY72244.1
TVY72041.1
TVY63301.1
EWY99288.1
TVY77434.1

0

99.75

g10346

0

99.73

g12760

0
0
0
0
0

99.89
99.72
99.61
99.85
99.81

g9698
g3656
g6640
g7224
g6026

* Note that g8604 and g9796 closely matched with two distinct Fusarium ergosterol biosynthesis genes. The above data are arranged
according to the pathway laid out by [17].

3. Discussion
Boxwood blight is an economically important disease caused by two sister fungal
species, Cps and Che, in landscape and plant nurseries across the globe [1,2]. As documented
in a previous study [3] and reaffirmed in the analysis presented herein (Table 1), these
two species differentially respond to select azole fungicides, the latter demonstrating a
five-fold greater EC50 tolerance to tetraconazole, and significantly reduced sensitivity
to propiconazole, both members of the azole class (Table 1). In this study, we applied
transcriptomic and bioinformatic analyses to gain insight into possible genetic determinants
for the observed differences in azole fungicide sensitivity.
Results from our previous study showed that a CYP51A pseudogene in Cps may
explain differential sensitivity to azoles [16]. As expected, few reads and no statistically
significant difference in gene expression were detected for the CYP51A pseudogene in
Cps. Given the stringent mapping parameters applied here, and the observation that the
few reads that were mapped to the CYP51A pseudogene mapped to the region upstream
of the premature stop codon, we can assume that a lack of functional CYP51A protein
expression could result in less compensatory ergosterol synthesis. By contrast, in Che, the
expression of both CYP51A and CYP51B gene paralogs could result in greater ergosterol
synthesis, as both CYP51A and CYP51B proteins are known to catalyze the same step in
the ergosterol pathway. In Candida albicans, chromosomal duplications of CYP51 are linked
to fluconazole-resistance [29]. Numerous studies demonstrate overexpression of CYP51 as
a mechanism for resistance to azoles (reviewed in [30]). Future complementation studies
with a functional CYP51A in Cps are warranted to carefully assess the impact of the CYP51A
pseudogene.
Although CYP51 and its paralogs receive the majority of focus when it comes to azole
fungicide resistance, the synthesis of ergosterol is a complex metabolic process driven
by over 20 genes from as many as three separate biochemical pathways [17,18]. Here we
identified potential ergosterol biosynthesis genes in Cps and Che, though, intriguingly, only
one biosynthesis gene, observed only in our sensitive Cps isolate (g12006, Tables 2 and 4),
showed significant overexpression following one hour after treatment. This finding sug-
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gests that Che is not reliant upon upregulation of ergosterol biosynthesis following exposure
to offset the inhibitory effects of tetraconazole. Interestingly, our observations differ from
those observed by [31] in Cochliobolus sativus. This pathogen, which exhibits emerging
fungicide resistance, displayed gene expression patterns whereby select ergosterol biosynthesis pathway genes were upregulated within hours of exposure. Our results in Che
may instead support the hypothesis that the presence of an additional, functional CYP51
paralog in Che could confer the increased tolerance towards azoles relative to Cps [16]. In
Schizosaccharomyces pombe, it was demonstrated that the addition of a gene encoding a C-5
sterol desaturase participating in ergosterol biosynthesis increased synthesis of ergosterol
and was correlated with improved tolerance towards exposure to extreme temperatures
and the presence of ethanol [32]. In light of the differential thermotolerance previously
reported in Cps and Che, comparative analyses of lipid profiles and ergosterol levels are
warranted in these two species [3].
Analysis of RNA-Seq expression profiles of tetraconazole-treated Cps and Che revealed
overexpressed genes predominantly associated with oxidoreductase activity, oxidationreduction processes, and monooxygenase activity, somewhat parallel to findings from
previous transcriptomic studies of azole sensitivity in fungi (Tables 3 and 4) [17,21,31].
The overexpression of cytochrome P450 monooxygenases is implicated in phase one of
xenobiotic detoxification, two of which have been functionally shown to play a role in
multidrug resistance in the turfgrass fungal pathogen, Clarireedia jacksonii (synonym =
Sclerotinia homoeocarpa) [20,21,33]. Furthermore, our candidate detoxification genes and
their differential expression patterns in Che and Cps were consistent with findings from
previous studies in both Cercospora beticola and Clarireedia jacksonii [17,21]. The putative
detoxification genes identified in the current study, including subsets of predicted transferases (Tables S5 and S6), could provide a more comprehensive list of putative targets
for functional characterization and/or serve as genetic markers for monitoring the evolution of resistance and potentially guiding future fungicide development. It should be
noted that gene deletion experiments in Cercospora beticola to verify the role of candidate
detoxification genes were inconclusive, while in Clarireedia jacksonii experiments validated
the function of two novel cytochrome P450 monooxygenases [17,21]. The amenability to
genetic transformation of Cps and Che remains unknown, but findings presented here serve
to build a knowledge base to enable such studies.
As reported by [21], non-synonymous polymorphism in a zinc transcription factor
led to gain-of-function resulting in overexpression of detoxification genes from the aforementioned gene families of the fungal xenome. The direct comparisons of gene expression
patterns relied on the apparent clonal nature of the sensitive and resistant fungal isolates of
Clarireedia jacksonii, which also facilitated screening for transcription factor polymorphism.
However, in the current study, the genetic divergence and the higher levels of genetic polymorphism between Cps and Che (warranting their placement in two separate species [3])
hampered efforts to readily identify polymorphism that could be linked to differential
expression of an assortment of genes representing multiple gene families. It should be
noted that a homolog of a negative regulator of nitrate metabolism genes, nmrA (g4897),
was underexpressed in tetraconazole-treated Cps (Table 2; Figure 1A, Figure 2B). Though
the linkage of this gene to azole sensitivity has not been previously reported, nmrA deletion
mutants have been shown to display reduced sensitivity to rapamycin and methylmethanesulfonate, presumably through rapamycin signaling and DNA-damage [34,35]. Another
candidate gene from Cps that could serve to influence expression levels of downregulated
genes shows similarity to RNQ1 (Table 2; Figure 1A, Figure 2B), a prion encoding gene that
is thought to have a role in epigenetics and phenotypic changes in Saccharomyces cerevisiae,
and which also mediates polyQ aggregation in concert with heat shock proteins in a Huntington’s Disease yeast model [36,37]. The significance of these genes in the response to an
inhibitory concentration of tetraconazole by Cps remains to be determined.
Numerous genes were downregulated in Cps in response to tetraconazole treatment
(Table 2; Figure 1A, Figure 2B), which may reflect the shunting of energy from housekeeping
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and maintenance to xenobiotic detoxification, analogous to findings from [21], which found
a several-fold greater abundance of genes downregulated in the sensitive isolates following
exposure to azole exposure, including genes encoding proteins with predicted association
with cell membranes. In both [21] and the current study, the sensitive isolate/species
were exposed to an azole concentration of five times the EC50 or above, presumably a
lethal dose, which could explain the much greater number of downregulated genes and
the fact that equivalent genes in Che tended to be unaffected/upregulated (Figure 1A).
Further, several of these genes were predicted to encode efflux transporter proteins (Table 2;
Figure 1A, Figure 2B) [13,20,25–28]. Given the sensitivity of Cps CT1 to tetraconazole and
its aforementioned exposure to an apparent lethal dosage of the chemical, fungal cells may
have in response triggered reduction in expression of suites of genes unrelated to azole
detoxification.
In Che, several overexpressed genes are associated with the first and third phases of
detoxification, with GO terms suggesting association with the cell membrane and oxidoreductase activity (Table 3; Figure 1B, Figure 2C, Figure 3C). A similar pattern is reported
in Cochliobolus sativus, Cercospora beticola and Clarireedia jacksonii which, following azole
treatment, display significant increases in gene expression for phase I cytochrome P450
proteins and phase III ABC-G transporters [17,21,31]. Of particular interest is a cytochrome
P450 gene described as a benzoate-4-monooxygenase, which showed significant overexpression (g8537). A previous study on antifungal response in Fusarium oxysporum and
Neocosmospora solani found a benzoate-4-monooxygenase to be overexpressed following
treatment with amphotericin b and posoconazole [38]. This gene, denoted CYP53, is a
member of the family of CYP450 enzymes exclusive to fungi that are involved in phenolic
detoxification. A study looking into natural compounds to target Cochliobolus lunatus
found that natural phenolic compounds inhibiting CYP53A15 activity showed antifungal
activity [39]. Perhaps this gene target may serve to inform novel fungicide treatments in
boxwood blight.
Few genes were underexpressed in Che following treatment, and, of note, included
several genes with predicted peptidase activity (Table 3; Figure 1B, Figure 2D). Aspartyl
peptidase activity has been shown to vary in response to azoles in a Candida albicans,
though future studies are necessary to begin to elucidate how peptidase activity can
influence azole sensitivity in fungi [40]. According to our conserved domain search, a
predicted tyrosinase gene (g7560) showed the highest degree of underexpression following
tetraconazole exposure, and though azole chemicals are known inhibitors of tyrosinase
activity, their impact on gene expression remains unclear [41]. A third gene of interest,
a predicted short-chain dehydrogenase, showed a minimal degree of underexpression
following tetraconazole exposure. In Aspergillus fumigatus, an important human pathogen,
deletion mutants for HorA (a mitochondrial short-chain dehydrogenase) showed increased
tolerance to azoles, suggesting to be indicative of a metabolic state linked to mitochondrial
impairment [42]. Taken together, diverse metabolic pathways appear to be downregulated
in Che to facilitate azole tolerance.
4. Materials and Methods
4.1. Estimating Effective Fungicide Concentrations for 50% and 85% Inhibition of Growth In Vitro
of Cps and Che
To identify fungicides to which Cps and Che are differentially tolerant, in vitro radialgrowth assays were used with a range of concentrations of fungicides, as listed in Table S1.
All assays were performed using Cps specimen CpsCT1s (hereafter: CT1) and Che type
specimen CB045 (hereafter: CB45); for tetraconazole and propiconazole, an additional
isolate of each species was used, as indicated in Table S1. All assays used commercial
formulations of fungicides (Table S1), added to autoclaved half-strength potato-dextrose
agar (half-PDA) in amounts producing the concentration ranges specified in Table S1,
based on labeled percentages of active ingredient. After thorough mixing, exactly 20 mL of
the amended media (or unamended control media) were then poured into 100 × 15 mm
plastic Petri dishes, which were then used the following day for inoculation with test
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isolates. Inoculations of amended media used 10-day-old cultures growing on Spezieller
Nährstoffarmer agar (SNA) [43], using 5.0-cm diameter plugs taken with a cork borer
from culture margins and placed in the center of the dish. Two replicates were used
for each isolate x treatment/control combination. After sealing plates with Parafilm M®
(Amcor, Zurich, Switzerland), cultures were incubated at room temperature in the dark
until control cultures (i.e., those not amended with fungicide) reached no less than 1.0 cm
from the dish perimeter, for the number of days as indicated in Table S1. Probit analysis
was used to determine the effective concentrations of fungicide necessary for 50% and 85%
inhibition of growth, as follows. Diameters were measured using digital calipers (Mahr
GmbH, Esslingen am Neckar, Germany), with measurements automatically uploaded
into a spreadsheet. After subtracting the inoculation-plug diameter, growth rates were
calculated by dividing adjusted diameters by the number of growth days, then normalized
by dividing by the growth rate of the unamended control. These normalized growth rates,
expressed as percentages, were then transformed to “probits” (probability units) [44]. The
linearized regression of probits against log-transformed fungicide concentrations was then
used to calculate EC50 and EC85 values, as listed in Table S1.
4.2. Genome Sequencing and Assembly
The genome sequences and predicted genes of Cps isolate CT1 (also known as isolate
CBS 139,707 and cpsCT1) and Che isolate CB45 (also known as CBS 138,102 and CB045)
reported in [16] were used to guide our differential expression analysis.
4.3. RNA Sequencing of Control versus Tetraconazole-Treated CT1 and CB45
Using 10 mL of half-strength PDB, conidia were washed from ten-day-old cultures of
CT1 and CB45, growing on half-strength PDA that had been scored four days previously
with a sterile scalpel to promote sporulation. After estimating conidia concentrations with
a hemocytometer, 1000 conidia were plated onto half-strength PDA and measured the
following day for viability. Based on those estimates, 10,000 putatively viable conidia were
used to inoculate each of the sixteen 50-mL tubes containing 20-mL of half-strength PDB,
placed at a 45◦ angle to maximize surface area, and allowed to grow at room temperature
without shaking for six days. The resulting mycelial mats were then transferred with
sterile spatulas to sixteen 50-mL tubes containing 20 mL of half-strength PDB, half of
which had been amended with 1.0 ppm tetraconazole (Minerva). After incubation on a
rocking platform for one hour, the mycelial mats were blotted on Kimwipes over ice, then
transferred to 2-mL tubes, plunged in liquid N2 , and lyophilized. The resulting lyophilized
mycelium was stored at −80 ◦ C for one day before RNA extraction using the Ambion
Trizol Plus kit (ThermoFisher Scientific, Waltham, MA, USA). Resulting RNAs were then
processed at the Yale Center for Genome Analysis (West Haven, CT, USA), where they
were first analyzed for quality and quantity on a Bioanalyzer (Agilent Technologies, Inc.,
Santa Clara, CA, USA), confirmed to have RIN scores of 9.0 or greater, and then processed
for 2 × 75-bp next-generation sequencing on an Illumina HiSeq-2500 (Illumina, Inc., San
Diego, CA, USA).
4.4. Genome Functional Annotation and Multi-Blast
Unless specified otherwise, the following procedures were performed using OmicsBox
software [45]. For both Calonectria genomes, the protein sequences of each predicted gene
were extracted using our gene annotation files. A blastp-fast search was performed in
September 2019 for each gene using the OmicsBox CloudBlast feature and the nr_v5 nonredundant protein sequence database using the following parameters: searches limited to
fungi (taxa: 4751); e-value ≤ 10−10 ; word size = 6; retaining only the top 10 blast hits for
each amino acid sequence. A blast description annotator and a filter removing matches
with regions of low complexity were applied. After performing the CloudBlast search, an
InterProScan analysis (CloudIPS) acquired protein domain information for each protein
in our files [46]. All available databases other than PatternScan, Coils, and MobiDBLite
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were selected for this analysis. Finally, Gene Ontology (GO) mapping was performed on
each protein sequence in the ensuing file using the most recently updated GO database
available [46].
The amino acid sequences for predicted genes in CB45 and CT1 were extracted using
OmicsBox [45]. Two multi-blasts (blastp) were performed using the CLC Genomics Workbench 11.0 (QIAGEN, 2017), the first querying CB45 genes against CT1 and the second
querying CT1 genes against those of CB45. The same parameters were used for both
BLAST searches (match = 2, mismatch = -3; gap existence cost = 5, extension cost = 2;
e-value ≤ 10−10 ; word size = 11; number of threads = 10; filter low complexity matches).
The two multi-blasts allowed for verification of whether we could find reliable matches of
equivalent CB45 genes in the CT1 genome.
4.5. Identification of Candidate Detoxification Genes
Genes with protein domains associated with the three phases of detoxification (oxidation, conjugation, and efflux) were mined from the CT1 and CB45 annotation files [20].
Amino acid sequences possessing any of the following four InterPro IDs were extracted
from the annotation files for both species: Cytochrome P450 (IPR001128; oxidation/ breakdown phase); Major Facilitator Superfamily (IPR020846; MFS, efflux phase); PDR-like
Subfamily G, Domain 1 (IPR034001; ABC-transporter, efflux phase); and PDR-like Subfamily G, Domain 2 (IPR034003; ABC-transporter, efflux phase). Transferases were extracted
by filtering the GO-annotated CT1 and CB45 genomes for the GO function name transferase
activity. The full lists of these genes are stored as Supplementary Tables S3–S6.
4.6. RNA-Seq Analysis of Control versus Tetraconazole-Treated Isolates
Three biological replicates were sequenced for control and tetraconazole-treated CT1
and CB45. Each biological replicate had three technical replicates. In total, there were
36 experimental units, each with a minimum of 4,000,000 total RNA-Seq reads.
All of the following procedures in this section were performed using the OmicsBox
software [45]. RNA-Seq reads were converted into FASTQ file format and read file quality
was assessed and poor reads were filtered out using the default parameters of FastQC
version 0.11.8 [47]. RNA-Seq reads meeting the quality threshold for CT1 and CB45
isolates were, respectively, aligned to the CT1 and CB45 reference genomes using the STAR
aligner software in the OmicsBox environment [48], with read overhang set to one base
pair lower than the maximum read length (75 base pairs) following the manufacturer’s
protocol. The annotation files of the two genomes were used to help guide the alignment.
The assigned minimum and maximum intron lengths were 20 base pairs and 2000 base
pairs, respectively [49]. Only one mismatch between the RNA-Seq read and the reference
genome was permitted, and reads were allowed to match with only one region in the
genome. These stringent mapping parameters were used to diminish the likelihood of false
matching between RNA reads and predicted genes.
Using the HTSeq 0.9.0 package, two read count tables were generated, one comparing
control and treated CT1 RNA-Seq reads and the other comparing control and treated CB45
reads [50]. The CT1 and CB45 structural annotation files were respectively used to acquire
the RNA-Seq read counts per gene. The counts were made according to read overlap with
the exon region of each gene (overlap mode: union; strand specificity: non strand specific).
Since Illumina RNA-Seq procedures generate high-quality reads with low error rates (less
than one base in 500), a high minimum mapping quality value of 25 (or an error rate of one
in 500 bases) was specified for this step.
Using the edgeR software package within the OmicsBox environment and our count
tables, separate differential expression analyses were run for CT1 and CB45 [51]. In both
instances, a count per million (CPM) filter was set to one and at least one sample needed to
reach this criterion. These parameters indicated that, for every million reads in a technical
replicate, at least one of the reads must map to a particular gene for that gene to be included
in the analysis. On average, there were between three and four million reads which
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mapped to a reference genome per replicate. Thus, for a given gene to be included in
this analysis, at least three reads were needed to map to that gene for a minimum of one
replicate. Since there were many genes whose samples possessed two or fewer matches,
this criterion was considered suitable to acquire reliable calculations of gene differential
expression. Additionally, the strict RNA-Seq alignment conditions decreased the likelihood
that any of the 75-bp reads were mapped to similar regions of incorrect genes, thereby
increasing confidence that only genes with reliably mapped reads were included in this
analysis. However, we had also run each differentially over- and underexpressed gene
against the NCBI Conserved Domain Search tool to further check the predicted functions
of these genes. Non-matching genes were described as encoding a hypothetical protein.
GraphPad Prism version 9.1.2 for Windows (GraphPad Software; San Diego, CA, USA,
www.graphpad.com) was used to generate plots displaying normalized gene expression
values and GO annotation counts for the differentially expressed genes in Cps CT1 and Che
CB45 treated with tetraconazole.
4.7. Identification of Ergosterol Biosynthesis Genes
A list of putative ergosterol biosynthesis genes were extracted from our annotated
Che CB45 genome using the GO name ergosterol biosynthetic process. A protein blast was
also performed against the CB45 genome (gap existence cost = 11; gap extension cost = 1;
e-value = 10−10 , word size = 3; number of threads = 4; filter low complexity matches; BLOSUM62) using various NCBI reference ergosterol biosynthesis genes from Fusarium species
(Table S6). This step was performed to try and capture putative ergosterol biosynthesis
genes missing from our GO name search. We used the pathway discussed by [17] to help
us guide our NCBI gene search. Using the two aforementioned multi-blasts (see Genome
functional annotation and multi-blast), we documented the closest matching genes in Cps CT1.
5. Conclusions
The findings presented here contribute to the body of knowledge on azole resistance
determinants in filamentous fungal plant pathogens, and though previous transcriptomics
studies of this nature have undertaken similar methodologies, the novelty of this study
lies in part in the phylogenetic relationship of Cps and Che, two distinct sister species,
and the presence of a CYP51A pseudogene in Cps. Follow up studies may have relevance
to novel azole resistance mechanisms in human fungal pathogens [6]. Many medically
important fungal pathogens, including Aspergillus fumigatus and Candida albicans, have
shown reduced sensitivity and/or resistance towards azole antifungals. Candida auris, a
species formally described in 2009 [52,53] is comprised of distinct clades, and treatment
for disease from this pathogen is complicated by azole resistance and resistance to other
major groups of medical antifungals through target gene mutations, gene duplications, and
increased expression of efflux proteins. As new reports of antifungal resistance continue to
emerge, an increasing need for novel drug targets arises. Future transcriptomic studies of
this nature will provide a roadmap to facilitate development of improved fungicides and
antifungal drugs for medicine, while serving to uncover cross-species patterns and novel
mechanisms underpinning multidrug resistance in fungi.
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